329
Views
84
CrossRef citations to date
0
Altmetric
Review

Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease

&
Pages 335-349 | Published online: 17 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (22)

Ru Ma, Hongling Su, Keping Jiao & Jian Liu. (2023) Association Between IL-17 and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1681-1690.
Read now
Mengjie Chen, Kan Xu, Yuting He, Jianjun Jin, Ruolin Mao, Lei Gao, Yi Zhang, Gang Wang, Peng Gao, Min Xie, Chunfang Liu & Zhihong Chen. (2023) CC16 as an Inflammatory Biomarker in Induced Sputum Reflects Chronic Obstructive Pulmonary Disease (COPD) Severity. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 705-717.
Read now
Junjie Peng, Min Wang, Yanqiu Wu, Yongchun Shen & Lei Chen. (2022) Clinical Indicators for Asthma-COPD Overlap: A Systematic Review and Meta-Analysis. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2567-2575.
Read now
Anastasia Papaporfyriou, Petros Bakakos, Georgios Hillas, Andriana I. Papaioannou & Stelios Loukides. (2022) Blood eosinophils in COPD: friend or foe?. Expert Review of Respiratory Medicine 16:1, pages 35-41.
Read now
Mei Yang, Ting Yang, Xiaoou Li, Diandian Li, Zenglin Liao, Yongchun Shen, Dan Xu, Lei Chen & Fuqiang Wen. (2021) Clinical Predictors of High Blood Eosinophils in Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2467-2474.
Read now
Chunrui Zou, Frank Li, Jiwoong Choi, Babak Haghighi, Sanghun Choi, Prathish K Rajaraman, Alejandro P Comellas, John D Newell$suffix/text()$suffix/text(), Chang Hyun Lee, R Graham Barr, Eugene Bleecker, Christopher B Cooper, David Couper, Meilan Han, Nadia N Hansel, Richard E Kanner, Ella A Kazerooni, Eric C Kleerup, Fernando J Martinez, Wanda O’Neal, Robert Paine$suffix/text()$suffix/text(), Stephen I Rennard, Benjamin M Smith, Prescott G Woodruff, Eirc A Hoffman & Ching-Long Lin. (2021) Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS). International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1477-1496.
Read now
Jonathan R Baker & Louise E Donnelly. (2021) Leukocyte Function in COPD: Clinical Relevance and Potential for Drug Therapy. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2227-2242.
Read now
Robson Prudente, Renata Ferrari, Carolina B Mesquita, Luiz H S Machado, Estefânia A T Franco, Irma Godoy & Suzana E Tanni. (2021) Peripheral Blood Eosinophils and Nine Years Mortality in COPD Patients. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 979-985.
Read now
Konstantinos Bartziokas, Athena Gogali & Konstantinos Kostikas. (2021) The Role of Blood Eosinophils in the Management of COPD: An Attempt to Answer the Important Clinical Questions. COPD: Journal of Chronic Obstructive Pulmonary Disease 18:6, pages 690-699.
Read now
Ali Saeedi-Boroujeni, Mohammad-Reza Mahmoudian-Sani, Roohangiz Nashibi, Sheyda Houshmandfar, Sima Tahmaseby Gandomkari & Ali Khodadadi. (2021) Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19. Immunopharmacology and Immunotoxicology 43:3, pages 247-258.
Read now
Aiyuan Zhou, Zijing Zhou, Dingding Deng, Yiyang Zhao, Jiaxi Duan, Wei Cheng, Cong Liu & Ping Chen. (2020) The Value of FENO Measurement for Predicting Treatment Response in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2257-2266.
Read now
Matthew J Hegewald, Benjamin D Horne, Frank Trudo, James L Kreindler, Yen Chung, Susan Rea & Denitza P Blagev. (2020) Blood Eosinophil Count and Hospital Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2629-2641.
Read now
Kjell E J Håkansson, Charlotte S Ulrik, Nina S Godtfredsen, Thomas Kallemose, Ove Andersen, Jesper Eugen-Olsen, Kristoffer Marsaa & Line J H Rasmussen. (2020) High suPAR and Low Blood Eosinophil Count are Risk Factors for Hospital Readmission and Mortality in Patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 733-743.
Read now
Jean-Pierre Llanos, Christopher F Bell, Elizabeth Packnett, Ellen Thiel, Debra E Irwin, Beth Hahn & Hector Ortega. (2019) Real-world characteristics and disease burden of patients with asthma prior to treatment initiation with mepolizumab or omalizumab: a retrospective cohort database study. Journal of Asthma and Allergy 12, pages 43-58.
Read now
Sebastian Majewski, Damian Tworek, Karolina Szewczyk, Justyna Kiszałkiewicz, Zofia Kurmanowska, Ewa Brzeziańska-Lasota, Hanna Jerczyńska, Adam Antczak, Wojciech Jerzy Piotrowski & Paweł Górski. (2019) Overexpression of chitotriosidase and YKL-40 in peripheral blood and sputum of healthy smokers and patients with chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1611-1631.
Read now
Takudzwa Mkorombindo & Mark T Dransfield. (2019) Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1779-1787.
Read now
Dharani K Narendra & Nicola A Hanania. (2019) Targeting IL-5 in COPD. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1045-1051.
Read now
Panaiotis Finamore, Simone Scarlata & Raffaele Antonelli Incalzi. (2019) Breath analysis in respiratory diseases: state-of-the-art and future perspectives. Expert Review of Molecular Diagnostics 19:1, pages 47-61.
Read now
Neil C Thomson. (2018) Challenges in the management of asthma associated with smoking-induced airway diseases. Expert Opinion on Pharmacotherapy 19:14, pages 1565-1579.
Read now
Donald P Tashkin & Charlie Strange. (2018) Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2587-2601.
Read now
Shenghua Jiang, Fenglian Shan, Youwen Zhang, Luning Jiang & Zhaozhong Cheng. (2018) Increased serum IL-17 and decreased serum IL-10 and IL-35 levels correlate with the progression of COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2483-2494.
Read now

Articles from other publishers (62)

Suh-Young Lee, Soon Ho Yoon & Hyunsook Hong. (2023) A Critical Systematic Review for Inhaled Corticosteroids on Lung Cancer Incidence: Not Yet Concluded Story. Tuberculosis and Respiratory Diseases 86:2, pages 120-132.
Crossref
Wei-jie Guan, Grace Oscullo, Meng-zhang He, Dan-yuan Xu, Jose Daniel Gómez-Olivas & Miguel Angel Martinez-Garcia. (2023) Significance and Potential Role of Eosinophils in Non-Cystic Fibrosis Bronchiectasis. The Journal of Allergy and Clinical Immunology: In Practice 11:4, pages 1089-1099.
Crossref
Natal'ya V. Vlasova, Lena M. Karamova, Linara A. Rafikova, Lilia G. Gizatullina, Elena R. Abdrakhmanova & Alla I. Borisova. (2022) Informative laboratory biomarkers for the diagnosis of respiratory diseases of occupational etiology in modern conditions. Russian Journal of Occupational Health and Industrial Ecology 62:12, pages 828-833.
Crossref
Laila Ashour Helala, Eman Badawy AbdelFattah & Hazem Mohamed Abd Elsalam. (2022) Blood and sputum eosinophilia in COPD exacerbation. The Egyptian Journal of Bronchology 16:1.
Crossref
Zhifa Han, Huiyuan Hu, Peiran Yang, Baicun Li, Guiyou Liu, Junling Pang, Hongmei Zhao, Jing Wang & Chen Wang. (2022) White blood cell count and chronic obstructive pulmonary disease: A Mendelian Randomization study. Computers in Biology and Medicine 151, pages 106187.
Crossref
Marcello Ferrari1, Michela Pizzini1, Lucia Cazzoletti2, Valentina Ermon1, Sergio De Marchi1, Luca Giuseppe Dalle Carbonare1, Ernesto Crisafulli1 & Francesco Spelta1. (2022) Circulating eosinophil levels and lung function decline in stable chronic obstructive pulmonary disease: a retrospective longitudinal study. Jornal Brasileiro de Pneumologia, pages e20220183.
Crossref
Si Cong Ye, Sameer Desai, Emma Karlsen, Eugenie Kwong, Pearce G. Wilcox & Bradley S. Quon. (2022) Association between elevated peripheral blood eosinophil count and respiratory outcomes in adults with cystic fibrosis. Journal of Cystic Fibrosis 21:6, pages 1048-1052.
Crossref
Andrew C. Retzinger & Gregory S. Retzinger. (2022) The Acari Hypothesis, III: Atopic Dermatitis. Pathogens 11:10, pages 1083.
Crossref
Parvarish Sharma, Daljeet Singh Dhanjal, Chirag Chopra, Murtaza M. Tambuwala, Sukhwinder Singh Sohal, Peter J. van der Spek, Hari S. Sharma & Saurabh Satija. (2022) Targeting eosinophils in chronic respiratory diseases using nanotechnology-based drug delivery. Chemico-Biological Interactions 365, pages 110050.
Crossref
Dagmar Abelone Dalin, Anders Løkke, Pernille Kristiansen, Charlotte Jensen, Kirsten Birkefoss, Hanne Rolighed Christensen, Nina Skavlan Godtfredsen, Ole Hilberg, Jeanett Friis Rohde, Anja Ussing, Charlotte Vermehren & Mina Nicole Händel. (2022) A systematic review of blood eosinophils and continued treatment with inhaled corticosteroids in patients with COPD. Respiratory Medicine 198, pages 106880.
Crossref
Lina Nurhussien, Choong-Min Kang, Petros Koutrakis, Brent A. Coull & Mary B. Rice. (2022) Air Pollution Exposure and Daily Lung Function in Chronic Obstructive Pulmonary Disease: Effect Modification by Eosinophil Level. Annals of the American Thoracic Society 19:5, pages 728-736.
Crossref
Aleksandar Dobric, Simone N. De Luca, Sarah J. Spencer, Steven Bozinovski, Michael M. Saling, Christine F. McDonald & Ross Vlahos. (2022) Novel pharmacological strategies to treat cognitive dysfunction in chronic obstructive pulmonary disease. Pharmacology & Therapeutics 233, pages 108017.
Crossref
Srinadh Annangi, Snigdha Nutalapati, Jamie Sturgill, Eric Flenaugh & Marilyn Foreman. (2022) Eosinophilia and fractional exhaled nitric oxide levels in chronic obstructive lung disease. Thorax 77:4, pages 351-356.
Crossref
Aliaksei G. Kadushkin, Anatoli D. Tahanovich, Lyudmila V. Movchan, Volha V. Dziadzichkina, Olga V. Levandovskaya & Tatsiana V. Shman. (2022) Nortriptyline overcomes corticosteroid resistance in NK and NKT-like cells from peripheral blood of patients with chronic obstructive pulmonary disease. Research Results in Pharmacology 8:1, pages 59-70.
Crossref
Kurt Brassington, Stavros Selemidis, Steven Bozinovski & Ross Vlahos. (2022) Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeutics. Clinical Science 136:6, pages 405-423.
Crossref
Daseul Hwang, Hyung Won Ryu, Ji-Won Park, Jung-Hee Kim, Doo-Young Kim, Jae-Hoon Oh, Ok-Kyoung Kwon, Sang-Bae Han & Kyung-Seop Ahn. (2022) Effects of 3′-isovaleryl-4′-senecioylkhellactone from Peucedanum japonicum Thunberg on PMA-Stimulated Inflammatory Response in A549 Human Lung Epithelial Cells . Journal of Microbiology and Biotechnology 32:1, pages 81-90.
Crossref
Meropi Karakioulaki & Daiana Stolz. 2022. Eosinophilic Lung Diseases. Eosinophilic Lung Diseases 100 118 .
Alan Martin, Dhvani Shah, Kerigo Ndirangu, Glenn A. Anley, Gabriel Okorogheye, Melanie Schroeder, Nancy Risebrough & Afisi S. Ismaila. (2022) Is single-inhaler triple therapy for COPD cost-effective in the UK? The IMPACT trial. ERJ Open Research 8:1, pages 00333-2021.
Crossref
Pradeesh Sivapalan & Jens-Ulrik Jensen. (2022) Biomarker bei chronisch-obstruktiven Lungenerkrankungen: Zunehmende Rolle von Eosinophilen und Procalcitonin. Kompass Pneumologie 10:2, pages 52-59.
Crossref
Pradeesh Sivapalan & Jens-Ulrik Jensen. (2022) Biomarkers in Chronic Obstructive Pulmonary Disease: Emerging Roles of Eosinophils and Procalcitonin. Journal of Innate Immunity 14:2, pages 89-97.
Crossref
Sarah Clarke & Peter Barnes. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine 549 558 .
Chandrakantsing V. Pardeshi, Sagar R. Pardeshi & Jitendra B. Naik. 2022. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases 219 258 .
Hanna Sandelowsky, Ulla Møller Weinreich, Bernt B. Aarli, Josefin Sundh, Kristian Høines, Georgios Stratelis, Anders Løkke, Christer Janson, Christian Jensen & Kjell Larsson. (2021) COPD – do the right thing. BMC Family Practice 22:1.
Crossref
Khojasteh Hoseinynejad, Maryam Radan, Mahin Dianat & Fereshteh Nejaddehbashi. (2021) Adipose-derived mesenchymal stem cells protects renal function in a rat model of emphysema. Tissue and Cell 73, pages 101613.
Crossref
Jonathan C. Weissler & Traci N. Adams. (2021) Eosinophilic Chronic Obstructive Pulmonary Disease. Lung 199:6, pages 589-595.
Crossref
Fabrizio Facchinetti, Maurizio Civelli, Dave Singh, Alberto Papi, Aida Emirova & Mirco Govoni. (2021) Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease. Frontiers in Pharmacology 12.
Crossref
Hsu-Hui Wang & Shih-Lung Cheng. (2021) From Biomarkers to Novel Therapeutic Approaches in Chronic Obstructive Pulmonary Disease. Biomedicines 9:11, pages 1638.
Crossref
Nicolas Roche, Philippe Devillier, Patrick Berger, Arnaud Bourdin, Daniel Dusser, Jean-François Muir, Yan Martinat, Philippe Terrioux & Bruno Housset. (2021) Individual trajectory-based care for COPD: getting closer, but not there yet. ERJ Open Research 7:4, pages 00451-2021.
Crossref
Louise Hosking, Astrid Yeo, Joshua Hoffman, Mathias Chiano, Dana Fraser, Soumitra Ghosh, David A. Lipson, Neil Martin, Lynn D. Condreay, Charles Cox & Pamela St Jean. (2021) Genetics plays a limited role in predicting chronic obstructive pulmonary disease treatment response and exacerbation. Respiratory Medicine 187, pages 106573.
Crossref
Martina Oriano, Andrea Gramegna, Francesco Amati, Alice D’Adda, Michele Gaffuri, Marco Contoli, Francesco Bindo, Edoardo Simonetta, Carlotta Di Francesco, Martina Santambrogio, Giovanni Sotgiu, Francesco Blasi & Stefano Aliberti. (2021) T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis. Biomedicines 9:7, pages 772.
Crossref
Kristián Brat, Jaromír Zatloukal, Kateřina Neumannová, Eva Voláková, Ondřej Kudela, Michal Kopecký, Marek Plutinský & Vladimír Koblížek. (2021) Chronic obstructive pulmonary disease: diagnosis and treatment of stable phase of disease; personalized treatment approach using phenotype features of the disease. Vnitřní lékařství 67:4, pages 230-239.
Crossref
Mathieu Fieldes, Chloé Bourguignon, Said Assou, Amel Nasri, Aurélie Fort, Isabelle Vachier, John De Vos, Engi Ahmed & Arnaud Bourdin. (2021) Targeted therapy in eosinophilic chronic obstructive pulmonary disease. ERJ Open Research 7:2, pages 00437-2020.
Crossref
Xiaofan Tu, Chantal Donovan, Richard Y. Kim, Peter A.B. Wark, Jay C. Horvat & Philip M. Hansbro. (2021) Asthma-COPD overlap: current understanding and the utility of experimental models. European Respiratory Review 30:159, pages 190185.
Crossref
Robert M. Burkes, Ralph J. Panos & Michael T. Borchers. (2021) How might endotyping guide chronic obstructive pulmonary disease treatment? Current understanding, knowledge gaps and future research needs. Current Opinion in Pulmonary Medicine 27:2, pages 120-124.
Crossref
Daniel Neunhäuserer, Alessandro Patti, David Niederseer, Bernhard Kaiser, Janne Cadamuro, Bernd Lamprecht, Andrea Ermolao, Michael Studnicka & Josef Niebauer. (2021) Systemic Inflammation, Vascular Function, and Endothelial Progenitor Cells after an Exercise Training Intervention in COPD. The American Journal of Medicine 134:3, pages e171-e180.
Crossref
Pradeesh Sivapalan, András Bikov & Jens-Ulrik Jensen. (2021) Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease. Diagnostics 11:2, pages 236.
Crossref
Benjamin David, Mona Bafadhel, Leo Koenderman & Antony De Soyza. (2021) Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait. Thorax 76:2, pages 188-195.
Crossref
Li-Yen Lee, Geena Suet Yin Hew, Meenu Mehta, Shakti D. Shukla, Saurabh Satija, Navneet Khurana, Krishnan Anand, Harish Dureja, Sachin Kumar Singh, Vijay Mishra, Pankaj Kumar Singh, Monica Gulati, Parteek Prasher, Alaa A.A. Aljabali, Murtaza M. Tambuwala, Lakshmi Thangavelu, Jithendra Panneerselvam, Gaurav Gupta, Flavia C. Zacconi, Madhur Shastri, Niraj Kumar Jha, Dikaia Xenaki, Ronan MacLoughlin, Brian G. Oliver, Dinesh Kumar Chellappan & Kamal Dua. (2021) Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities. Life Sciences 267, pages 118973.
Crossref
Mario Cazzola, Maria Gabriella Matera & Paola Rogliani. (2021) Blood Eosinophils in Chronic Obstructive Pulmonary Disease: Is There Enough Evidence?. US Respiratory & Pulmonary Diseases 6:1, pages 31.
Crossref
Bashar N. Alzghoul, Mohammad As Sayaideh, Brian F. Moreno, Saminder K. Singh, Ayoub Innabi, Raju Reddy, Eric S. Papierniak & Hassan M Alnuaimat. (2021) Pulmonary hypertension in eosinophilic versus noneosinophilic COPD . ERJ Open Research 7:1, pages 00772-2020.
Crossref
Linlin Liu, Ying Luan, Ling Xiao, Ning Wang, Jing Wang & Zhaobo Cui. (2021) The predictive value of serum procalcitonin for non-invasive positive pressure ventilation in the patients with acute exacerbation of chronic obstructive pulmonary disease. Medicine 100:16, pages e25547.
Crossref
Shvetank Bhatt, Jovita Kanoujia, A. N. Nagappa & K. Sreedhara R. Pai. 2021. Targeting Cellular Signalling Pathways in Lung Diseases. Targeting Cellular Signalling Pathways in Lung Diseases 127 146 .
Pradeesh Sivapalan, Barbara Bonnesen & Jens-Ulrik Jensen. (2020) Novel Perspectives Regarding the Pathology, Inflammation, and Biomarkers of Acute Respiratory Distress Syndrome. International Journal of Molecular Sciences 22:1, pages 205.
Crossref
Jaromir Zatloukal, Kristian Brat, Katerina Neumannova, Eva Volakova, Karel Hejduk, Eva Kocova, Ondrej Kudela, Michal Kopecky, Marek Plutinsky & Vladimir Koblizek. (2020) Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society. Biomedical Papers 164:4, pages 325-356.
Crossref
Javier Checa & Josep M. Aran. (2020) Airway Redox Homeostasis and Inflammation Gone Awry: From Molecular Pathogenesis to Emerging Therapeutics in Respiratory Pathology. International Journal of Molecular Sciences 21:23, pages 9317.
Crossref
Guangming Dai, Yajuan Ran, Jiajia Wang, Xingru Chen, Junnan Peng, Xinglong Li, Huojin Deng, Min Xiao & Tao Zhu. (2020) Clinical Differences between Eosinophilic and Noneosinophilic Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Multicenter Cross-Sectional Study. Mediators of Inflammation 2020, pages 1-9.
Crossref
Bryce W.Q. Tan, Wei Liang Sim, Jit Kong Cheong, Win Sen Kuan, Thai Tran & Hui Fang Lim. (2020) MicroRNAs in chronic airway diseases: Clinical correlation and translational applications. Pharmacological Research 160, pages 105045.
Crossref
Kwun M. Fong & Tobias Welte. (2020) World Lung Day: what, why, and where to?. American Journal of Physiology-Lung Cellular and Molecular Physiology 319:3, pages L527-L533.
Crossref
Dave Singh, Henrik Watz, Kai Michael Beeh, Oliver Kornmann, Brian Leaker, Brendan Colgan, Germano Lucci, Aida Emirova, Marie Anna Nandeuil, Debora Santoro, Deborah Balzano & Mirco Govoni. (2020) COPD sputum eosinophils: relationship to blood eosinophils and the effect of inhaled PDE4 inhibition. European Respiratory Journal 56:2, pages 2000237.
Crossref
Narongkorn Saiphoklang & Chanya Chomchoey. (2020) Eosinophilia and parasitic infestations in patients with chronic obstructive pulmonary disease. Scientific Reports 10:1.
Crossref
Charalambos Michaeloudes, Pankaj K. Bhavsar, Sharon Mumby, Bingling Xu, Christopher Kim Ming Hui, Kian Fan Chung & Ian M. Adcock. (2020) Role of Metabolic Reprogramming in Pulmonary Innate Immunity and Its Impact on Lung Diseases. Journal of Innate Immunity 12:1, pages 31-46.
Crossref
Sriram Sridhar, Hao Liu, Tuyet-Hang Pham, Gautam Damera & Paul Newbold. (2019) Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases. Respiratory Research 20:1.
Crossref
S N Avdeev, N V Trushenko, Z M Merzhoeva, M S Ivanova & E V Kusraeva. (2019) Eosinophilic inflammation in chronic obstructive pulmonary disease. Terapevticheskii arkhiv 91:10, pages 144-152.
Crossref
Cheng-Sen Cai & Jun Wang. (2019) Blood eosinophil level to predict chronic obstructive pulmonary disease clinical outcomes. Chinese Medical Journal 132:19, pages 2373-2375.
Crossref
Brianna Atto, Mathew Suji Eapen, Pawan Sharma, Urs Frey, Alaina J. Ammit, James Markos, Collin Chia, Josie Larby, Greg Haug, Heinrich C. Weber, George Mabeza, Stephen Tristram, Stephen Myers, Dominic P. Geraghty, Katie L. Flanagan, Philip M. Hansbro & Sukhwinder Singh Sohal. (2019) New therapeutic targets for the prevention of infectious acute exacerbations of COPD: role of epithelial adhesion molecules and inflammatory pathways. Clinical Science 133:14, pages 1663-1703.
Crossref
Gábor Sirokmány & Miklós Geiszt. (2019) The Relationship of NADPH Oxidases and Heme Peroxidases: Fallin' in and Out. Frontiers in Immunology 10.
Crossref
Wadah Ibrahim, Michael Wilde, Rebecca Cordell, Dahlia Salman, Dorota Ruszkiewicz, Luke Bryant, Matthew Richardson, Robert C Free, Bo Zhao, Ahmed Yousuf, Christobelle White, Richard Russell, Sheila Jones, Bharti Patel, Asia Awal, Rachael Phillips, Graham Fowkes, Teresa McNally, Clare Foxon, Hetan Bhatt, Rosa Peltrini, Amisha Singapuri, Beverley Hargadon, Toru Suzuki, Leong L Ng, Erol Gaillard, Caroline Beardsmore, Kimuli Ryanna, Hitesh Pandya, Tim Coates, Paul S Monks, Neil Greening, Christopher E Brightling, Paul Thomas & Salman Siddiqui. (2019) Assessment of breath volatile organic compounds in acute cardiorespiratory breathlessness: a protocol describing a prospective real-world observational study. BMJ Open 9:3, pages e025486.
Crossref
A. G. Kadushkin, A. D. Taganovich, L. V. Movchan, T. V. Shman, V. K. Panasyuk & G. K. Novskaya. (2019) Use of the routine complete blood count to predict steroid resistance in patients with chronic obstructive pulmonary disease. Russian Pulmonology 28:6, pages 681-692.
Crossref
Jinju Lee & Hun Sik Kim. (2019) The Role of Autophagy in Eosinophilic Airway Inflammation. Immune Network 19:1.
Crossref
Sarah H. Landis, Jeanne M. Pimenta, Shibing Yang, Chris Compton, Neil Barnes & Guy Brusselle. (2019) Association between blood eosinophils and acute exacerbation of COPD risk in patients with COPD in primary care. Respiratory Medicine: X 1, pages 100011.
Crossref
Daisy Karina Aguilar-López, Carlos Olvera-Sandoval, Diego Estrada-Luna, Jeannett Alejandra Izquierdo-Vega, Ashutosh Sharma & Gabriel Betanzos-Cabrera. 2019. Oxidative Stress in Lung Diseases. Oxidative Stress in Lung Diseases 3 26 .
Venkataramana K. Sidhaye, Kristine Nishida & Fernando J. Martinez. (2018) Precision medicine in COPD: where are we and where do we need to go?. European Respiratory Review 27:149, pages 180022.
Crossref